Does Your Patient Have Ehlers-Danlos Syndrome?
Ehlers-Danlos Syndrome in the MSK Patient PM&R News  •  September 20, 2020 Guest post by Chris Duncan, MD Candidate, Tulane University School of Medicine Ehlers-Danlos Syndrome (EDS) is an umbrella term for a heterogeneous group of inherited connective tissue disorders characterized by symptoms including, but not limited to, skin hyperextensibility, joint hypermobility, and vascular fragility.1 It is a result of genetic mutations that cause defects in the formation of types I, III, and/or V collagen, which can manifest with pathologies in collagen-rich tissues like skin, tendons, ligaments, joints, and blood vessels.1 The variety of genes that can be involved leads to a variety [...]